- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00944398
Impact of Targeted Zinc Fortification Programs on Plasma Zinc Concentration
February 18, 2010 updated by: University of California, Davis
Evaluation of the Use of Plasma Zinc Concentration for Assessing the Impact of Targeted and Mass Zinc Fortification Programs
The purpose of the study is to evaluate the use of plasma zinc concentration for assessing the impact of targeted zinc fortification programs.
Study Overview
Status
Completed
Conditions
Detailed Description
The objectives of the present study are to determine whether plasma zinc concentration changes in response to additional zinc consumption, as provided by zinc-fortified cereal-based complementary foods fed to young children. The following specific steps will be completed:
- Zinc-fortified complementary foods and breads prepared from zinc-fortified cereal flours will be developed with assistance from experts in food technology.
- A two-week feeding trial will be implemented to assess the change in plasma zinc concentration among young children who receive: a) the zinc-fortified cereal porridge and a liquid vitamin preparation between meals; b) a non-zinc-fortified cereal porridge and a liquid vitamin preparation between meals [negative control group]; or c) a non-zinc-fortified cereal porridge and a zinc-containing liquid vitamin preparation between meals [positive control group].
Study Type
Interventional
Enrollment (Actual)
98
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Dakar, Senegal
- Helen Keller International
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
1 year to 1 year (Child)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- apparently healthy
Exclusion Criteria:
- severe malnutrition
- severe anemia
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Zinc fortified group
Daily consumption of zinc-fortified complementary food
|
Daily consumption
Other Names:
Liquid placebo supplement
Other Names:
|
Placebo Comparator: Non-fortified group
Daily consumption of non-fortified complementary food and placebo supplement.
|
Liquid placebo supplement
Other Names:
Non-fortified complementary food.
Other Names:
|
Experimental: Zinc supplement group
Daily consumption of zinc supplement and non-fortified complementary food.
|
Non-fortified complementary food.
Other Names:
Liquid supplement containing zinc sulfate
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Plasma zinc concentration
Time Frame: 3 weeks
|
3 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2009
Primary Completion (Actual)
September 1, 2009
Study Completion (Actual)
October 1, 2009
Study Registration Dates
First Submitted
July 21, 2009
First Submitted That Met QC Criteria
July 22, 2009
First Posted (Estimate)
July 23, 2009
Study Record Updates
Last Update Posted (Estimate)
February 19, 2010
Last Update Submitted That Met QC Criteria
February 18, 2010
Last Verified
February 1, 2010
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 200817275
- 107008
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Zinc Deficiency
-
NobelpharmaCompleted
-
Swiss Federal Institute of TechnologyHarvestPlusCompleted
-
Prof. Michael B. ZimmermannUniversité d'Abomey-CalaviCompleted
-
NobelpharmaCompleted
-
International Centre for Diarrhoeal Disease Research...University of California, DavisCompleted
-
University of California, DavisHelen Keller International; Université Polytechnique de Bobo-Dioulasso; NutrisetCompletedZinc DeficiencyBurkina Faso
-
Swiss Federal Institute of TechnologyHarvestPlusCompletedZinc Deficiency
-
Wageningen UniversityETH Zurich; Maseno UniversityCompletedZinc DeficiencyKenya
-
University of California, DavisUSDA, Western Human Nutrition Research CenterCompleted
-
University of California, DavisHelen Keller International; Cheikh Anta Diop University, Senegal; Global Alliance...Completed
Clinical Trials on Zinc fortified food
-
GlaxoSmithKlineCompletedGrowth and DevelopmentIndia
-
Purdue UniversityCompletedIron-deficiency | Vitamin A DeficiencySenegal
-
Swiss Federal Institute of TechnologyUniversity of ZurichCompleted
-
Tampere UniversityKamuzu University of Health SciencesCompleted
-
Cornell UniversityArogyavaram Medical Centre; SNDT Women's UniversityActive, not recruitingIron Deficiency | Vitamin A Deficiency | Zinc DeficiencyIndia
-
Tampere UniversityCompleted
-
University of California, DavisHelen Keller International; Cheikh Anta Diop University, Senegal; Global Alliance...Completed
-
Hospices Civils de LyonCompletedCardiometabolic Risk | Abdominal ObesityFrance
-
Tampere UniversityAcademy of Finland; Foundation for Paediatric Research, FinlandCompleted
-
International Food Policy Research InstituteUnited States Agency for International Development (USAID); Cornell University and other collaboratorsCompleted